FARD (RaDiCo Cohort) (RaDiCo-FARD) (FARD)
National Cohort for Evaluation of the Burden of Rare Skin Diseases
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
A observational or N/A phase clinical study on Albinism and Ectodermal Dysplasia, this trial is actively recruiting participants. The trial is conducted by Institut National de la Santé Et de la Recherche Médicale, France and has accumulated 5 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Mar 2025 — Feb 2026 [monthly]
Recruiting
-
Sep 2024 — Mar 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Aug 2023 — Jul 2024 [monthly]
Recruiting
First recorded
Mar 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institut National de la Santé Et de la Recherche Médicale, France
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bobigny, France , Bordeaux, France , Créteil, France , Dijon, France , Limoges, France , Marseille, France , Montpellier, France , Nice, France , Paris, France , Reims, France and 3 more locations